Anthony Piscopio is the founder of OnKure. OnKure has raised $61M in total funding. Latest round: Series C. Based in Boulder, Colorado, USA.
Anthony D. Piscopio (also known as Tony Piscopio) is the co-founder, Chief Executive Officer, and President of OnKure Therapeutics, a precision oncology company focused on epigenetics-based drug discovery. He co-founded the company with Xuedong Liu and has guided it through multiple funding rounds, including a $7M Series A in 2018 and a $54M Series C in 2023. OnKure is headquartered in Boulder, Colorado.
Full founder directory · Investor directory · Company funding database · Fundraising library